MaxCyte Inc. | Key People and Executives
Douglas A. Doerfler
President, Chief Executive Officer & Director
Ronald E. Holtz
CFO, Secretary & Executive Director
J. Stark Thompson
Independent Non-Executive Chairman
Richard H. Douglas
Independent Non-Executive Director
Arthur M. Mandell
Independent Non-Executive Director
John Joseph Johnston
Independent Non-Executive Director
Stanley C. Erck
Independent Non-Executive Director
William W. Brooke
Independent Non-Executive Director
Douglas A. Doerfler
President, Chief Executive Officer & Director
Bradley Calvin
Executive VP-Global Commercial Operations
Ronald E. Holtz
CFO, Secretary & Executive Director
Claudio Dansky Ullmann
Chief Medical Officer
Debra K. Bowes
Executive VP-Business & Strategic Development
James Brady
Director-Technical Applications
Thomas Michael Ross
Executive Vice President-Global Sales
Kathryn Wekselman
Vice President-Regulatory
Maher Masoud
Vice President-Legal
J. Stark Thompson
Independent Non-Executive Chairman
Richard H. Douglas
Independent Non-Executive Director
Arthur M. Mandell
Independent Non-Executive Director
John Joseph Johnston
Independent Non-Executive Director
Stanley C. Erck
Independent Non-Executive Director
William W. Brooke
Independent Non-Executive Director
| Address |
22 Firstfield Road
Gaithersburg Maryland 20878
United States
|
|
Employees
|
- |
| Website |
http://www.maxcyte.com |
| Updated |
07/08/2019 |
| MaxCyte, Inc. enages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include MaxCyte STX, MaxCyte VLX, and MaxCyte GT. |
